CHNC China Infrastructure Construct

Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company

Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company

HOUSTON, TX, April 17, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, has the pleasure to announce former football player, David Irving, as its new spokesperson.

The commitment and devotion of Mr. Irving to the game of football has not only been remarkable but a game changer. Moreover, one of the exceptional determinations he’s had during his career is to advocate for cannabis use in sports. Following his suspension after testing positive for a drug test, he has publicly reached out to the NFL to change outdated policies and the collective bargaining agreement (CBA). The outcome was the reduction of the testing window and the eradication of suspensions for NFL players.

In addition, as a patient, he’s been vocal about the medical use of cannabis and its benefits in treating his anxiety, sleep, and pain management due to the multiple injuries he’s suffered throughout his career. As a result, he has repelled the stigma surrounding the plant and its use in the professional sports field while acknowledging and expressing the severe and long-term side effects of available treatments, such as opioids, that are widely accepted in medical and athletic practice.

As a former four year-player for the Dallas Cowboys, and as a triumphant playmaker with the Las Vegas Raiders he was able to convey a clear and sound statement that cannabis goes beyond smoking and also encapsulates the palliative properties for a better quality of life. In addition, he also taught us that it's about awareness, better policies, justice, and, most of all, education.

“We welcome Mr. Irving with open arms, trusting that his experience will boost CBIH to the next level as we continue to develop our company’s great success,” says Henry Levinski, Vice President/Treasurer of CBIH. “He has taken risks bigger than anyone can imagine when trying to reach his goals and has encountered a favorable outcome in the process,” he adds.

With this trajectory, our company is thrilled to have acquired an alliance with Mr. Irving as CBIH´s Spokesperson. We believe his allegiance, passion, and hard work align with our company’s values and vision. Therefore, reinforcing our commitment to science, education, and medicine while continuing to attempt to upgrade and update the current legal frame and provide better opportunities for patients, caretakers, cannabis users, and professionals about the medical and industrial uses of the plant.

Thank you, Mr. Irving, for continuing to bring hope to new generations in the medical cannabis space. Gratitude for your best touchdown ever!

To learn more visit:

For more information contact us at:

817/528-2475 for English

214/733-0868 for Spanish

911/1121798903 for Italian

962/796269233 for Arabic

55/11966497868 for Portuguese



EN
17/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassific...

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CBIH is proud to announce that Brian Cuban, Esq., a distinguished attorney, best-selling author, mental health advocate, and esteemed member of our Advisory Board, has officially joined the Reclassification Team. Mr. Cuban will play a crucial role in representing CBIH at the upcoming DEA hearings on marijuana rescheduling. Brian Cuban, the younger brother of entrepreneur Mark Cuban, brings a unique combination of personal recovery experience and professional advocacy to ...

 PRESS RELEASE

Cannabis Bioscience International Holdings (CBIH) Announces Partnershi...

Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products HOUSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to announce a groundbreaking partnership with Stephen Gould, marking a monumental step forward in the manufacturing and distribution of CBIH’s advanced medical product line. This collaboration represents a shared commitment to excellence and innovation in the healthcare industry. Stephen Gould, a company with a remarkable presence...

 PRESS RELEASE

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Resche...

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing HOUSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (CBIH) continues its unwavering advocacy for cannabis as a legitimate medicine by formally petitioning to have Ms. Alexis Bortell, long-time cannabis advocate and patient, to serve as a witness in the upcoming DEA hearing on marijuana rescheduling. Alexis Bortell has been a leading voice in the fight for medical cannabis access since being diagnosed with intractable epilepsy at the age of seven. After enduring years...

 PRESS RELEASE

A Letter from the Desk of CBIH

A Letter from the Desk of CBIH HOUSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings CEO Dante Picazo Addresses Cannabis Reclassification and DEA Hearings Dear Community, On Monday, December 2, I had the honor of representing Cannabis Bioscience International Holdings (CBIH) at the DEA Hearing Docket No. 1362 and Hearing Docket No. 24-44, focused on the reclassification of cannabis. Being chosen to speak on behalf of not only our company but also medicine, science, and patients is a privilege and a profound responsibility. CBIH remains committed to activ...

 PRESS RELEASE

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hear...

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing HOUSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing on cannabis reclassification. Representing CBIH at this critical event in Arlington, Virginia, is Dante Picazo, the company’s esteemed Director and CEO, bringing years of expertise and leadership in the medical cannabis industry to Docket No. 1362, Hearing Docket No. 24-44. Mr. Picazo has presented a comprehensive 78-page statement that un...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch